JPH068249B2 - Topical agent for suppressing melanin production - Google Patents
Topical agent for suppressing melanin productionInfo
- Publication number
- JPH068249B2 JPH068249B2 JP63140404A JP14040488A JPH068249B2 JP H068249 B2 JPH068249 B2 JP H068249B2 JP 63140404 A JP63140404 A JP 63140404A JP 14040488 A JP14040488 A JP 14040488A JP H068249 B2 JPH068249 B2 JP H068249B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- melanin production
- glabrene
- glabridin
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000008099 melanin synthesis Effects 0.000 title claims description 10
- 239000003860 topical agent Substances 0.000 title 1
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 claims description 22
- NGGYSPUAKQMTNP-UHFFFAOYSA-N Glabrene Chemical compound C1=C(O)C=C2OCC(C3=C4OC(C=CC4=C(O)C=C3)(C)C)=CC2=C1 NGGYSPUAKQMTNP-UHFFFAOYSA-N 0.000 claims description 16
- KKLOCFOZPFGVBB-UHFFFAOYSA-N Glabrene Natural products C1=C(O)C=C2OCC(C3=CC=C4OC(C=CC4=C3O)(C)C)=CC2=C1 KKLOCFOZPFGVBB-UHFFFAOYSA-N 0.000 claims description 16
- LBQIJVLKGVZRIW-ZDUSSCGKSA-N glabridin Chemical compound C1([C@H]2CC3=CC=C4OC(C=CC4=C3OC2)(C)C)=CC=C(O)C=C1O LBQIJVLKGVZRIW-ZDUSSCGKSA-N 0.000 claims description 13
- 229940093767 glabridin Drugs 0.000 claims description 13
- PMPYOYXFIHXBJI-ZDUSSCGKSA-N glabridin Natural products C1([C@H]2CC=3C=CC4=C(C=3OC2)CCC(O4)(C)C)=CC=C(O)C=C1O PMPYOYXFIHXBJI-ZDUSSCGKSA-N 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 11
- 239000004480 active ingredient Substances 0.000 claims description 4
- 239000000284 extract Substances 0.000 description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 244000303040 Glycyrrhiza glabra Species 0.000 description 9
- 102000003425 Tyrosinase Human genes 0.000 description 9
- 108060008724 Tyrosinase Proteins 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 240000004670 Glycyrrhiza echinata Species 0.000 description 8
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 239000000741 silica gel Substances 0.000 description 8
- 229910002027 silica gel Inorganic materials 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 229940010454 licorice Drugs 0.000 description 6
- 239000006210 lotion Substances 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- -1 aliphatic alcohols Chemical class 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 235000017443 Hedysarum boreale Nutrition 0.000 description 3
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 208000003351 Melanosis Diseases 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229960004441 tyrosine Drugs 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 241000756137 Hemerocallis Species 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 description 1
- FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 description 1
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、メラニン生成抑制外用剤に関するものであ
る。なお、この明細書で外用剤とは、化粧料のほか、外
用に用いられる軟膏剤、ローション剤、リニメント剤、
乳剤などの医薬部外品を包含する。TECHNICAL FIELD The present invention relates to an external preparation for suppressing melanin production. In addition, in this specification, in addition to cosmetics, the external preparations include ointments, lotions, liniments, which are used externally.
Includes quasi drugs such as emulsions.
皮膚が黒くなる原因の一つとして、アミノ酸の一種であ
るチロシンにチロシナーゼが作用することによる色素・
メラニンの生成がある。そこで、従来、アスコルビン
酸、プラセンターエキス、コウジ酸、桑白皮エキス、チ
ロシナーゼ活性阻害作用を有する各種動植物抽出物(た
とえば特開昭58−225004号公報、特開昭61−
12209号公報)等を化粧料に配合することにより、
上記原因による皮膚黒色化やシミ、ソバカスの発生を防
止することが提案され、一部、実施されている。しかし
ながら、アスコルビン酸類は酸化され易く、それを配合
した化粧料の変色、変臭を招くという欠点がある。また
動植物抽出物系のものは、その効果が十分でなく、ま
た、安定性や色、臭気等の点でも問題があり、実用可能
なものはほとんどない。One of the causes of darkening of the skin is the pigment caused by the action of tyrosinase on tyrosine, which is a type of amino acid.
There is melanin production. Therefore, conventionally, ascorbic acid, placenta extract, kojic acid, mulberry bark extract, and various animal and plant extracts having a tyrosinase activity inhibitory action (for example, JP-A-58-225004, JP-A-61-
No. 12209 gazette) and the like are added to the cosmetics,
It has been proposed and partially implemented to prevent skin blackening, spots, and freckles due to the above causes. However, ascorbic acids are apt to be oxidized, which causes the discoloration and odor of cosmetics containing them. Further, animal and plant extract-based products are not sufficiently effective, and have problems in stability, color, odor, etc., and there are almost no practical ones.
本発明の目的は、上述のような現状に鑑み、従来公知の
チロシナーゼ活性阻害物質よりも少量ですぐれた作用を
示す物質を用いた使い易く且つ効果的なメラニン生成抑
制外用剤を提供することにある。In view of the above-mentioned current situation, an object of the present invention is to provide an easy-to-use and effective external preparation for suppressing melanin production, which uses a substance exhibiting superior action in a smaller amount than conventionally known tyrosinase activity inhibitors. is there.
本発明によるメラニン生成抑制外用剤は、下記構造式の
グラブリジンまたは(および)グラブレンを有効成分と
して含有するものである。The external preparation for suppressing melanin production according to the present invention contains glabridine or / and glabrene having the following structural formula as an active ingredient.
グラブリジンおよびグラブレンは、天然に甘草の1種Gl
ycyrrhiza glabra Linn var(ソ連、アフガン、トル
コカンゾウ)に微量含まれているが、その薬理作用につ
いての報告はなく、グラブリジンについて抗菌作用が、
またグラブレンについて抗酸化作用および抗菌作用が、
それぞれ知られているにすぎない。 Grabridine and Grabrene are naturally licorice Gl
It is contained in ycyrrhiza glabra Linn var (Soviet Union, Afghanistan, Turkish liquorice) in trace amounts, but there is no report on its pharmacological effect, and antibacterial effect on glabridin is
In addition, the antioxidant and antibacterial effects of glabrene,
Each is only known.
本発明者らは、グラブリジンおよびグラブレンが優れた
チロシナーゼ活性阻害作用を示すことを初めて見いだ
し、本発明を完成した。The present inventors have for the first time found that glabridin and glabrene exhibit excellent tyrosinase activity inhibitory effects, and completed the present invention.
原料甘草・Glycyrrhiza glabra Linn varからグラブ
リジンおよびグラブレンを抽出するには、この甘草の根
部またはその水(もしくはアンモニア水)抽出残渣(た
とえばグリチルリチンを抽出した残渣)を有機溶媒で抽
出する。使用可能な抽出用有機溶媒の例としては、メタ
ノール、エタノール等の低級脂肪族アルコール;アセト
ン等の低級脂肪族ケトン;ジオキサン、エチルエーテル
等の低級脂肪族エーテル;塩化メチレン、クロロホルム
など炭素原子数1〜4のハロゲン化炭化水素;酢酸エチ
ル、酢酸n-ブチル、酢酸イソブチルなど炭素原子数3〜
7のエステル;n-ヘキサン、ベンゼン等の炭化水素類;
およびこれらの溶媒の2種以上の混合物がある。これら
の溶媒により上記甘草から有効成分を抽出するには、被
処理原料を約5〜15倍量の溶媒に浸漬して還流下に加
熱するか、約5〜15倍量の溶媒に常温で浸漬すればよ
い。得られる抽出液から溶媒を留去して得られる抽出物
は、茶褐色の固体である。この抽出物は、そのままで
も、チロシナーゼ活性阻害作用の点では十分利用可能な
ものであるが、必要ならば、脱臭、脱色等の精製処理を
施し、さらにはグラブリジンおよびグラブレンの純品に
近い純度まで精製してから用いてもよい。To extract glabridin and glabrene from the raw material licorice Glycyrrhiza glabra Linn var, the root portion of this licorice or its water (or ammonia water) extraction residue (for example, the residue from which glycyrrhizin has been extracted) is extracted with an organic solvent. Examples of usable organic solvents for extraction include lower aliphatic alcohols such as methanol and ethanol; lower aliphatic ketones such as acetone; lower aliphatic ethers such as dioxane and ethyl ether; methylene chloride, chloroform and the like having 1 carbon atom. ~ 4 halogenated hydrocarbons; ethyl acetate, n-butyl acetate, isobutyl acetate, etc.
Ester of 7; hydrocarbons such as n-hexane and benzene;
And there are mixtures of two or more of these solvents. In order to extract the active ingredient from the licorice with these solvents, the raw material to be treated is immersed in about 5 to 15 times the amount of solvent and heated under reflux, or immersed in about 5 to 15 times the amount of solvent at room temperature. do it. The extract obtained by distilling the solvent from the obtained extract is a brown solid. This extract, as it is, is sufficiently usable in terms of tyrosinase activity inhibitory action, but if necessary, it is subjected to purification treatment such as deodorization and decolorization, and further to a purity close to that of pure glabridin and glabrene. It may be used after being purified.
本発明のメラニン生成抑制外用剤の形態は前述のように
多岐にわたり、色白作用を特徴とする化粧料の場合も、
たとえば化粧水、クリーム、乳液、パックなど、各種皮
膚用化粧料が有り得る。The melanin production suppressing external preparation of the present invention has various forms as described above, and also in the case of cosmetics characterized by a whitening effect,
For example, there may be various skin cosmetics such as lotions, creams, emulsions and packs.
グラブリジンおよびグラブレンの好ましい配合量は、剤
種、期待されるメラニン生成抑制効果の程度などによつ
ても異なるが、通常0.0007〜0.05%程度が適
当である。The preferred blending amount of glabridine and glabrene varies depending on the type of the agent, the expected degree of melanin production inhibitory effect, etc., but is usually 0.0007 to 0.05% or so.
以下、実施例を示して本発明を説明する。なお、実施例
1において用いた甘草は、いずれもGlycyrrhiza glabra
Linn varである。Hereinafter, the present invention will be described with reference to examples. The licorice used in Example 1 was Glycyrrhiza glabra.
It is Linn var.
実施例1(甘草抽出例) 甘草の根の細切物100gを1の酢酸エチルとともに
2時間還流下に加熱して、酢酸エチル可溶成分を抽出し
た。抽出液を分離した抽出残渣について同様の操作を繰
り返し、合計1.8の抽出液を得た。この抽出液の溶
媒を留去し、さらに減圧乾燥して、グラブリジンおよび
グラブレンを含有する抽出物2.8gを得た。これを抽
出物Aとする。Example 1 (licorice extraction example) 100 g of finely sliced licorice root was heated under reflux with 1 part of ethyl acetate for 2 hours to extract an ethyl acetate-soluble component. The same operation was repeated for the extraction residue obtained by separating the extract, and a total of 1.8 extracts were obtained. The solvent of this extract was distilled off, and the residue was dried under reduced pressure to obtain 2.8 g of an extract containing glabridine and glabrene. This is designated as Extract A.
甘草根細切物100gを1の塩化メチレンに常温で5
時間浸漬して、塩化メチレン可溶成分を抽出した。抽出
液を分離した抽出残渣について同様の操作を繰返し、合
計1.7の抽出液を得た。この抽出液の溶媒を留去
し、さらに減圧乾燥して、グラブリジンおよびグラブレ
ンを含有する抽出物2.5gを得た。これを抽出物Bと
する。100 g of licorice root shredded in 1 methylene chloride at room temperature
It was immersed for a period of time to extract the methylene chloride-soluble component. The same operation was repeated for the extraction residue obtained by separating the extract, and a total of 1.7 extracts were obtained. The solvent of this extract was distilled off and further dried under reduced pressure to obtain 2.5 g of an extract containing glabridine and glabrene. This is designated as Extract B.
n-ヘキサン5部にアセトン2部を混合した抽出溶媒1
で甘草根細切物100gを2時間還流下に加熱して、溶
媒可溶成分を抽出した。抽出液を分離した抽出残渣につ
いて同様の操作を繰り返し、合計1.6の抽出液を得
た。この抽出液の溶媒を留去し、さらに減圧乾燥して、
グラブリジンおよびグラブレンを含有する抽出物2.3
gを得た。これを抽出物Cとする。Extraction solvent 1 with 2 parts of acetone mixed with 5 parts of n-hexane
Then, 100 g of the licorice root shredded product was heated under reflux for 2 hours to extract a solvent-soluble component. The same operation was repeated for the extraction residue obtained by separating the extract, and a total of 1.6 extracts were obtained. The solvent of this extract was distilled off, and further dried under reduced pressure,
Extract 2.3 containing Grabridine and Grabrene
g was obtained. This is designated as Extract C.
実施例2(グラブリジンおよびグラブレンの精製例) 実施例1による抽出物A2.8gを少量のクロロホルム
に溶解し、得られた溶液をシリカゲル(ワコーゲルC-3
00,和光純薬工業株式会社)にまぶしたのち、乾燥す
る。このシリカゲルを、あらかじめシリカゲル500g
を充填したカラムの上に積層充填し、クロロホルム/メ
タノール混合液(30:1)で溶出し、グラブリジン含
有画分およびグラブレン含有画分を採取した。目的物の
溶出は、薄層クロマトグラフイー(展開溶媒:クロロホ
ルム/メタノール;担体:メルク社シリカゲル60F;
検出方法:19%硫酸噴霧後加熱)によつて確認した。
各画分の溶媒を減圧下に留去して、固形のグラブリジン
画分0.8gおよびグラブレン画分0.16gを得た。Example 2 (purification example of glabridin and glabrene) 2.8 g of the extract A according to Example 1 was dissolved in a small amount of chloroform, and the resulting solution was subjected to silica gel (Wakogel C-3
00, Wako Pure Chemical Industries, Ltd.) and dry. This silica gel is preliminarily treated with 500 g of silica gel.
Was stacked and packed on a column packed with and eluted with a chloroform / methanol mixture (30: 1) to collect a glabridine-containing fraction and a grabrene-containing fraction. Thin layer chromatography (developing solvent: chloroform / methanol; carrier: Merck silica gel 60F;
Detection method: 19% sulfuric acid spraying and heating).
The solvent of each fraction was distilled off under reduced pressure to obtain 0.8 g of solid glabridine fraction and 0.16 g of glabrene fraction.
このグラブリジン画分を少量のメタノールに溶解し、溶
液を逆相シリカゲル(30〜50メツシユ,ODSG-3,水
戸化学技術研究所製)にまぶして乾燥する。この逆相シ
リカゲルを、あらかじめ逆相シリカゲル200gを充填
したカラムの上に積層充填し、水/アセトニトリル(3
0:70)で分離溶出し、グラブリジン含有画分を採取
した。減圧下に溶媒を留去して、精製グラブリジン画分
0.45gを得た。これをさらにアセトン5mlに溶解
し、5℃に一夜冷却すると、グラブリジンの淡黄色結晶
0.4gが得られた。This glabridin fraction is dissolved in a small amount of methanol, and the solution is sprinkled on reverse phase silica gel (30-50 mesh, ODSG-3, manufactured by Mito Chemical Research Laboratory) and dried. This reversed-phase silica gel was stacked and packed on a column previously packed with 200 g of reversed-phase silica gel, and water / acetonitrile (3
The mixture was separated and eluted at 0:70) and the glabridin-containing fraction was collected. The solvent was distilled off under reduced pressure to obtain a purified glabridine fraction 0.45 g. This was further dissolved in 5 ml of acetone and cooled to 5 ° C. overnight to obtain 0.4 g of pale yellow crystals of glabridin.
同様にしてグラブレン画分を精製し、精製グラブレン画
分0.1gを得、これをヘキサン3mlから再結晶させ
て、無色のグラブレン結晶0.08gを得た。In the same manner, the Grabrene fraction was purified to obtain 0.1 g of the purified Grabrene fraction, which was recrystallized from 3 ml of hexane to obtain 0.08 g of colorless Grabrene crystals.
比較例1(異種甘草抽出物の調製) Glycyrrhiza echinata L.(スペインカンゾウ)、Glycy
rrhiza inflata Batal(中国シンキヨウカンゾウ)及び
Glycyrrhiza uralensis Fisher et De Candelle(中国
東北西北カンゾウ)について、それぞれ抽出物Aの場合
と同様の酢酸エチルによる抽出を行い、抽出物x、yお
よびzを得た。Comparative Example 1 (Preparation of heterogeneous licorice extract) Glycyrrhiza echinata L. (Spanish Licorice), Glycy
rrhiza inflata Batal (Chinese Daylily) and
Glycyrrhiza uralensis Fisher et De Candelle (eastern northwestern Chinese licorice) was extracted with ethyl acetate in the same manner as in the case of the extract A to obtain extracts x, y and z.
比較例2(Glycyrrhiza glabra Linn varの水抽出物
の調製) 実施例1で用いたGlycyrrhiza glabra Linn varの根
を粗砕し、その100gを精製水1000mlに浸漬し、
蒸気浴上で2時間加熱して水溶性成分を抽出した。さら
に、抽出液を分離した残渣について同様の抽出操作を行
い、抽出液合計18000mlを得た。これを減圧下で濃
縮したのち減圧乾燥して、抽出物dを得た(収量20.
6g)。Comparative Example 2 (Preparation of water extract of Glycyrrhiza glabra Linn var) The root of Glycyrrhiza glabra Linn var used in Example 1 was roughly crushed, and 100 g thereof was immersed in 1000 ml of purified water,
The water-soluble components were extracted by heating on a steam bath for 2 hours. Furthermore, the same extraction operation was performed on the residue from which the extract was separated, and a total of 18000 ml of the extract was obtained. This was concentrated under reduced pressure and then dried under reduced pressure to obtain an extract d (yield 20.
6g).
実施例3 上記各例で得られた抽出物A〜C、dおよびx〜z、グ
ラブリジンおよびグラブレン(結晶化品)、アスコルビ
ン酸について、チロシナーゼ阻害活性を測定した。測定
法は次のとおりである。Example 3 The tyrosinase inhibitory activity was measured for the extracts A to C, d and x to z, glabridin and glabrene (crystallized products), and ascorbic acid obtained in each of the above examples. The measuring method is as follows.
[試薬] A:L-チロジン溶液(1.0mg/ml)0.5ml B:M/15リン酸緩衝液(pH6.8)2.0ml C:1%硫酸銅溶液0.05ml D:チロシナーゼ溶液(6mg/100ml)0.5ml [試料溶液] 試料をエタノールに溶解した後、M/50リン酸緩衝液で希
釈する。1回2mlを使用。[Reagent] A: L-tyrosine solution (1.0 mg / ml) 0.5 ml B: M / 15 phosphate buffer (pH 6.8) 2.0 ml C: 1% copper sulfate solution 0.05 ml D: Tyrosinase solution (6 mg / 100 ml) 0.5 ml [Sample solution] The sample is dissolved in ethanol and then diluted with M / 50 phosphate buffer. Use 2 ml once.
[操作] 試料溶液にA、B、C、Dの各液を加え、37℃で1
時間インキユベートしたのち640nmの吸光度Atを測定
する。[Operation] Add each of A, B, C, and D solutions to the sample solution, and add 1 at 37 ° C.
Measuring the absorbance A t of 640nm After time Inkiyubeto.
E液の代わりにm/50リン酸緩衝液2.0mlを加え、
と同様に操作して、640nmの吸光度Abを測定する。Add 2.0 ml of m / 50 phosphate buffer instead of solution E,
Using the same method as, measuring the absorbance A b of 640 nm.
D液の代わりに精製水を0.5ml加え、と同様に操
作して、640nmの吸光度Aoを測定する。Purified water (0.5 ml) is added instead of the liquid D, and the same operation as in (4) is performed to measure the absorbance A o at 640 nm.
種々の濃度の試料溶液について上記測定を行い、次式
によるチロシナーゼ阻害率が50%になる試料添加量を
内挿法で求める。The above-mentioned measurement is carried out for sample solutions having various concentrations, and the sample addition amount by which the tyrosinase inhibition rate by the following formula is 50% is determined by the interpolation method.
また、上記各抽出物について、高速液体クロマトグラフ
イーによりグラブリジンおよびグラブレンの定量を行な
つた。分析条件は次のとおりである。まず試料約25mg
を精秤し、これをエタノールに溶かして全量を100ml
とする。別に、グラブリジンおよびグラブレンの標準液
(濃度約4mg/100mlエタノール)を用意する。試料溶液
と標準液を下記条件の高速液体クロマトグラフイーにか
ける。 Further, with respect to each of the above extracts, glabridin and glabrene were quantified by high performance liquid chromatography. The analysis conditions are as follows. First about 25mg of sample
Is precisely weighed, dissolved in ethanol and the total volume is 100 ml.
And Separately, a standard solution of glabridin and glabrene (concentration about 4 mg / 100 ml ethanol) is prepared. The sample solution and standard solution are subjected to high performance liquid chromatography under the following conditions.
カラム:オクタデシルシリル化シリカゲル (Wakopak 5C18,4.6mmφ×250mm) カラム温度:40℃ 移動相:アセトニトリル−2%酢酸(60:40) 流速1ml/min 検出器:紫外吸光光度計(波長282nm) 注入量:20μl 測定結果は表1のとおりであつた。Column: Octadecyl silylated silica gel (Wakopak 5C18, 4.6 mmφ x 250 mm) Column temperature: 40 ° C Mobile phase: Acetonitrile-2% acetic acid (60:40) Flow rate 1 ml / min Detector: Ultraviolet absorptiometer (wavelength 282 nm) Injection amount : 20 μl The measurement results are shown in Table 1.
実施例4 エタノール 15.0% モノラウリン酸ポリオキシエチレンソルビタン (20EO) 1.0 パラオキシ安息香酸 0.2 香料 0.2 抽出物A 0.02 精製水 72.6 グリセリン 5.0 1,3-ブチレングリコール 6.0 色素 適量 上記(室温にて混合し均一溶液としたもの)を用意
し、を攪拌しつつを徐々に添加して、シミ防止化粧
水を調製した。 Example 4 Ethanol 15.0% Polyoxyethylenesorbitan monolaurate (20EO) 1.0 Paraoxybenzoic acid 0.2 Perfume 0.2 Extract A 0.02 Purified water 72.6 Glycerin 5.0 1,3-butylene Glycol 6.0 Dye An appropriate amount of the above (prepared as a uniform solution by mixing at room temperature) was prepared, and was slowly added with stirring to prepare a stain-proof lotion.
この化粧水を30〜40才の女性20人に毎日被用させ
た。2週間使用後のシミの軽減度を調べたところ、効果
あり7名、やや効果あり10名、効果なし3名で、有効
率は85%であり、優れたシミ防止作用を有することが
確認された。This lotion was applied to 20 women aged 30 to 40 every day. When the degree of reduction of the spots after 2 weeks of use was examined, it was confirmed that 7 people had an effect, 10 people had an effect, 3 people had no effect, and the effective rate was 85%, which had an excellent anti-spot effect. It was
実施例5 ステアリン酸 15% セタノール 1.0 グラブリジン 0.003 水酸化カリウム 0.7 グリセリン 5.0 プロピレングリコール 3.0 殺菌・防腐剤 適量 精製水 75% 香料 0.3 上記を82℃に、を80℃に、それぞれ加熱溶解
し、攪拌しながらをに徐々に加えて乳化を行う。5
0℃にてを添加し、30℃まで冷却して、シミ、ソバ
カス防止バニシングクリームを調製した。Example 5 Stearic acid 15% Cetanol 1.0 Glabridine 0.003 Potassium hydroxide 0.7 Glycerin 5.0 Propylene glycol 3.0 Sterilizing / preservative suitable amount Purified water 75% Perfume 0.3 The above to 82 ° C. Each of them is melted by heating at 80 ° C. and gradually added while stirring to emulsify. 5
Was added at 0 ° C. and cooled to 30 ° C. to prepare a spot and freckle prevention vanishing cream.
実施例6 スクワラン 5.0% ワセリン 2.0 サラシミツロウ 0.5 セスキオレイン酸ソルビタン 0.8 ポリオキシエチレンオレイルエーテル (20EO) 1.2 グラブレン 0.01 殺菌・防腐剤 適量 プロピレングリコール1%水溶液 5.0 エタノール 3.2 カルボキシビニルポリマー(1%水溶液) 18.0 水酸化ナトリウム 0.1 精製水 63.9 香料 0.3 上記を75℃に、を73℃に、それぞれ加熱溶解
し、攪拌しながらをに徐々に加えて乳化させる。そ
の後を加えてから30℃に冷却して、シミ、ソバカス
防止エモリエントローシヨンを調製した。Example 6 Squalane 5.0% Vaseline 2.0 Sarah beeswax 0.5 Sorbitan sesquioleate 0.8 Polyoxyethylene oleyl ether (20EO) 1.2 Grabrene 0.01 Sterilizer / preservative Appropriate amount Propylene glycol 1% aqueous solution 5 0.0 Ethanol 3.2 Carboxyvinyl polymer (1% aqueous solution) 18.0 Sodium hydroxide 0.1 Purified water 63.9 Perfume 0.3 The above ingredients were heated and dissolved at 75 ° C. and 73 ° C., respectively, and stirred. While gradually adding, emulsify. After the addition, the mixture was cooled to 30 ° C. to prepare a stain- and freckle-preventing emollient lotion.
実施例3の結果から明らかなように、グラブリジンおよ
びグラブレンはチロシナーゼ阻害活性が強く、少量で有
効であり、副作用もなく、淡黄色(グラブリジン)また
は無色(グラブレン)であり、また、化学的にも安定な
物質であるから、多くの化粧料、外用剤等に自由に配合
することができる。したがつて本発明によれば、従来よ
りも使い易く効果も優れた様々なメラニン生成抑制外用
剤を提供することが可能になる。As is clear from the results of Example 3, glabridin and glabrene have strong tyrosinase inhibitory activity, are effective in a small amount, have no side effects, are pale yellow (glabridine) or colorless (glabrene), and are chemically chemically active. Since it is a stable substance, it can be freely mixed with many cosmetics, external preparations and the like. Therefore, according to the present invention, it becomes possible to provide various external preparations for suppressing melanin production, which are easier to use and more effective than conventional ones.
Claims (2)
とを特徴とするメラニン生成抑制外用剤。1. An external preparation for suppressing melanin production, which contains glabridin as an active ingredient.
を特徴とするメラニン生成抑制外用剤。2. An external preparation for suppressing melanin production, which comprises glabrene as an active ingredient.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63140404A JPH068249B2 (en) | 1988-06-09 | 1988-06-09 | Topical agent for suppressing melanin production |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63140404A JPH068249B2 (en) | 1988-06-09 | 1988-06-09 | Topical agent for suppressing melanin production |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH01311011A JPH01311011A (en) | 1989-12-15 |
| JPH068249B2 true JPH068249B2 (en) | 1994-02-02 |
Family
ID=15267977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63140404A Expired - Lifetime JPH068249B2 (en) | 1988-06-09 | 1988-06-09 | Topical agent for suppressing melanin production |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH068249B2 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3195683B2 (en) * | 1993-03-01 | 2001-08-06 | 丸善製薬株式会社 | Skin cosmetics |
| JPH0812518A (en) * | 1994-06-27 | 1996-01-16 | Maruzen Pharmaceut Co Ltd | Skin cosmetic |
| US5874463A (en) | 1994-10-24 | 1999-02-23 | Ancira; Margaret | Hydroxy-kojic acid skin peel |
| AU4126799A (en) * | 1998-06-08 | 1999-12-30 | Fytokem Products Inc. | Tyrosinase inhibitors from plants |
| FR2822067B1 (en) * | 2001-03-16 | 2006-05-26 | Led Evolution Dermatolog | DEPIGMENTING DERMATOLOGICAL COMPOSITION BASED ON GLABRIDINE |
| EP1859834B1 (en) | 2005-03-15 | 2015-05-06 | Maruzen Pharmaceuticals Co., Ltd. | Anti-inflammatory agent |
| EP2219600A4 (en) * | 2007-11-19 | 2012-09-12 | Stiefel Laboratories | Topical cosmetic skin lightening compositions and methods of use thereof |
| US9241893B2 (en) | 2007-11-19 | 2016-01-26 | Stiefel Laboratories, Inc. | Topical cosmetic skin lightening compositions and methods of use thereof |
| US9364424B2 (en) | 2007-11-19 | 2016-06-14 | Stiefel Laboratories, Inc. | Topical cosmetic skin lightening compositions and methods of use thereof |
| FR3019040B1 (en) * | 2014-03-31 | 2016-03-11 | Arkema France | COSMETIC COMPOSITION FOR SKIN LIGHTENING |
| WO2016040757A1 (en) * | 2014-09-12 | 2016-03-17 | The Procter & Gamble Company | Cosmetic compositions and methods for inhibiting melanin synthesis |
| JP6873598B2 (en) * | 2015-12-22 | 2021-05-19 | ロレアル | Improved topical delivery system for active ingredients |
| CN105902423A (en) * | 2016-04-15 | 2016-08-31 | 欧标(广州)化妆品有限公司 | Whitening mask composition for uniformizing skin color and brightening skin |
| EP3829556B1 (en) * | 2018-07-30 | 2023-09-06 | Unilever IP Holdings B.V. | Compositions comprising active botanical ingredients |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60214721A (en) * | 1984-04-06 | 1985-10-28 | Inahata Koryo Kk | Cosmetic composition for preventing liver-spot |
| JPS61122209A (en) * | 1984-11-16 | 1986-06-10 | Osaka Chem Lab | Cosmetic composition for preventing skins from staining and spotting |
-
1988
- 1988-06-09 JP JP63140404A patent/JPH068249B2/en not_active Expired - Lifetime
Non-Patent Citations (1)
| Title |
|---|
| 奥田拓也編「天然薬物辞典」株式会社広川書店発行(昭和61年4月15日)P.99〜100 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH01311011A (en) | 1989-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3135943B2 (en) | Whitening agent | |
| JPH068249B2 (en) | Topical agent for suppressing melanin production | |
| JPS63316711A (en) | Beautifying and whitening cosmetic | |
| JPH05306231A (en) | Skin external preparation | |
| JP3800611B2 (en) | Whitening agent or pigmentation ameliorating agent | |
| JP2810107B2 (en) | Cosmetic composition for skin | |
| JP2952636B2 (en) | Melanin production inhibitor, method for producing the same, and whitening cosmetic containing the same | |
| JP2749218B2 (en) | Cosmetic composition for whitening | |
| JPS63135310A (en) | Cosmetic | |
| JPH07157494A (en) | Novel isoflavone glycoside and cosmetic containing the same | |
| JPH0899891A (en) | Skin external agent | |
| JPH03127714A (en) | Skin cosmetic | |
| JPH05124950A (en) | Beautifying and whitening cosmetic composition | |
| JP3052104B2 (en) | Skin cosmetics | |
| JP3150841B2 (en) | External preparation for skin | |
| JP2004345969A (en) | Tyrosinase inhibitor and bleaching cosmetic using the same | |
| JPH01139517A (en) | Cosmetic | |
| CN101106971B (en) | Cosmetic compositions containing sophora alopecuroides extracts | |
| KR100757130B1 (en) | Skin whitening cosmetics containing verazine and epi-verazine with melanin inhibitory activity | |
| JPH07238011A (en) | Skin-beautifying cosmetic composition | |
| JPH06321760A (en) | Skin beautifying agent | |
| JP4457133B2 (en) | External preparation for skin and whitening agent | |
| JP4319417B2 (en) | Melanin production deficiency treatment | |
| JP2000256175A (en) | Cosmetic composition | |
| JP4037836B2 (en) | Hyaluronidase activity inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080202 Year of fee payment: 14 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090202 Year of fee payment: 15 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090202 Year of fee payment: 15 |